FdaApplication
NDA 020903
Identifiers
- fda_app_no: NDA020903
Properties
| Property | Value |
|---|---|
| applicant_name | MERCK SHARP AND DOHME CORP |
| application_type | NDA |
| approval_date | 1998-06-03 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REBETOL | RIBAVIRIN | 200MG **Indicated for use and comarketed with Interferon ALFA-2B, Recombinant (INTRON A), as Rebetron Combination Therapy** | CAPSULE;ORAL |
| REBETOL | RIBAVIRIN | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
2 products